Your healthcare provider will review your medical history, discuss your health goals, and determine whether semaglutide is an appropriate treatment option
All suspected side effects should be reported to the trial team and to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
Frontiers in Endocrinology, 5 , Article 13
A company acquiring Pharmacyclics in 2015 needed Imbruvicas entire patent wall to be defensible, not just its composition-of-matter patent
These guidelines help ensure that the medication is prescribed to individuals who are most likely to benefit from its weight-reducing effects
Reported side effects may include nausea, vomiting, diarrhea, and constipation, among others